NeuroPace, Inc.
NPCE
$8.42
-$0.14-1.64%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.42% | 4.93% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.42% | 4.93% | |||
| Cost of Revenue | 3.98% | -1.82% | |||
| Gross Profit | 4.56% | 7.13% | |||
| SG&A Expenses | 20.35% | 9.12% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.66% | 10.16% | |||
| Operating Income | -32.58% | -40.90% | |||
| Income Before Tax | -31.29% | -25.50% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -31.29% | -25.50% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -31.29% | -25.50% | |||
| EBIT | -32.58% | -40.90% | |||
| EBITDA | -32.78% | -41.41% | |||
| EPS Basic | -25.75% | -19.26% | |||
| Normalized Basic EPS | -25.76% | -14.24% | |||
| EPS Diluted | -25.75% | -19.26% | |||
| Normalized Diluted EPS | -25.76% | -14.24% | |||
| Average Basic Shares Outstanding | 4.39% | 5.24% | |||
| Average Diluted Shares Outstanding | 4.39% | 5.24% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||